Publications by authors named "Nuha Khalfay"
Article Synopsis
- * An analysis of patient records showed that 64% of those diagnosed with a UTI received antibiotics, despite only 28% displaying actual symptoms; emergency room patients were especially overtreated.
- * The findings highlight the concerning trend of overdiagnosis and overtreatment of UTIs, particularly in acute care settings, which could exacerbate antibiotic resistance and compromise patient evaluation.
Antibiotic Switches in Urinary Tract Infection Are Associated With Atypical Symptoms and Emergent Care.
Urogynecology (Phila)
March 2024
Importance: Given worsening global antibiotic resistance, antimicrobial stewardship aims to use the shortest effective duration of the most narrow-spectrum, effective antibiotic for patients with specific urinary symptoms and laboratory testing consistent with urinary tract infection (UTI). Inappropriate treatment and unnecessary antibiotic switching for UTIs harms patients in a multitude of ways.
Objective: This study sought to analyze antibiotic treatment failures as measured by antibiotic switching for treatment of UTI in emergent and ambulatory care.
Objectives: Examine whether preoperative antibiotics in class I/clean abdominal gynaecologic surgery decrease the incidence of surgical site infections (SSI).
Methods: Retrospective cohort study at academic safety net hospital of patients undergoing class I laparoscopic or open gynaecologic surgery between November 2013 and September 2017. Performance improvement initiative to administer preoperative antibiotics to all surgical patients starting July 2016.
An Analysis of Stated Insurance Coverage and Estimated Patient-Incurred Costs of Treatments for Lower Urinary Tract Symptoms.
Urogynecology (Phila)
February 2023
Importance: Lower urinary tract symptoms (LUTSs) affect more than half of all adults, yet clinical care remains poor. Anecdotally, patients and health care providers express frustration over obstacles from insurance providers to obtaining LUTS treatment; however, little information concerning actual patient-incurred costs for these medications is available.
Objectives: This study aimed to analyze coverage by 5 major insurance companies and patient costs for LUTS pharmacotherapy.